{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:48:19Z","timestamp":1790542099304,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T00:00:00Z","timestamp":1435190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12035-015-9255-6","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T06:17:02Z","timestamp":1435126622000},"page":"1054-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice"],"prefix":"10.1007","volume":"52","author":[{"given":"Supriti","family":"Samantaray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varduhi H.","family":"Knaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren L.","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,25]]},"reference":[{"key":"9255_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/9781444397970","volume-title":"Parkinson\u2019s disease: non-motor and non-dopaminergic features","author":"CW Olanow","year":"2011","unstructured":"Olanow CW, Stocchi F, Lang AE (2011) Parkinson\u2019s disease: non-motor and non-dopaminergic features. Wiley, Chichester"},{"issue":"Pt 1","key":"9255_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awr277","volume":"135","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM et al (2012) Alzheimer\u2019s disease pattern of brain atrophy predicts cognitive decline in Parkinson\u2019s disease. Brain 135(Pt 1):170\u2013180. doi: 10.1093\/brain\/awr277","journal-title":"Brain"},{"key":"9255_CR3","doi-asserted-by":"crossref","first-page":"576091","DOI":"10.1155\/2013\/576091","volume":"2013","author":"NC Palavra","year":"2013","unstructured":"Palavra NC, Naismith SL, Lewis SJ (2013) Mild cognitive impairment in Parkinson\u2019s disease: a review of current concepts. Neurol Res Int 2013:576091. doi: 10.1155\/2013\/576091","journal-title":"Neurol Res Int"},{"issue":"12","key":"9255_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.33588\/rn.5912.2014082","volume":"59","author":"Y Bocanegra","year":"2014","unstructured":"Bocanegra Y, Trujillo-Orrego N, Pineda D (2014) Dementia and mild cognitive impairment in Parkinson\u2019s disease: a review. Rev Neurol 59(12):555\u2013569","journal-title":"Rev Neurol"},{"issue":"3","key":"9255_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1471-4159.2011.07320.x","volume":"118","author":"VH Knaryan","year":"2011","unstructured":"Knaryan VH, Samantaray S, Le Gal C, Ray SK, Banik NL (2011) Tracking extranigral degeneration in animal models of Parkinson\u2019s disease: quest for effective therapeutic strategies. J Neurochem 118(3):326\u2013338. doi: 10.1111\/j.1471-4159.2011.07320.x","journal-title":"J Neurochem"},{"issue":"7","key":"9255_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/1743132812Y.0000000073","volume":"34","author":"F Sanchez-Lopez","year":"2012","unstructured":"Sanchez-Lopez F, Tasset I, Aguera E, Feijoo M, Fernandez-Bolanos R, Sanchez FM, Ruiz MC, Cruz AH et al (2012) Oxidative stress and inflammation biomarkers in the blood of patients with Huntington\u2019s disease. Neurol Res 34(7):721\u2013724. doi: 10.1179\/1743132812Y.0000000073","journal-title":"Neurol Res"},{"issue":"4","key":"9255_CR7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG (2008) Glial reactions in Parkinson\u2019s disease. Mov Disord 23(4):474\u2013483. doi: 10.1002\/mds.21751","journal-title":"Mov Disord"},{"issue":"4","key":"9255_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-2008-13408","volume":"13","author":"AR Kamer","year":"2008","unstructured":"Kamer AR, Dasanayake AP, Craig RG, Glodzik-Sobanska L, Bry M, de Leon MJ (2008) Alzheimer\u2019s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis 13(4):437\u2013449","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"9255_CR9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291","journal-title":"Neurology"},{"issue":"3","key":"9255_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.12134","volume":"141","author":"S Amor","year":"2014","unstructured":"Amor S, Woodroofe MN (2014) Innate and adaptive immune responses in neurodegeneration and repair. Immunology 141(3):287\u2013291. doi: 10.1111\/imm.12134","journal-title":"Immunology"},{"issue":"6","key":"9255_CR11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jnc.12374","volume":"127","author":"S Samantaray","year":"2013","unstructured":"Samantaray S, Knaryan VH, Shields DC, Banik NL (2013) Critical role of calpain in spinal cord degeneration in Parkinson\u2019s disease. J Neurochem 127(6):880\u2013890. doi: 10.1111\/jnc.12374","journal-title":"J Neurochem"},{"issue":"1","key":"9255_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87(1):10\u201320. doi: 10.1016\/j.brainresbull.2011.10.004","journal-title":"Brain Res Bull"},{"issue":"Pt 3","key":"9255_CR13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awp333","volume":"133","author":"S Levesque","year":"2010","unstructured":"Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML (2010) Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133(Pt 3):808\u2013821. doi: 10.1093\/brain\/awp333","journal-title":"Brain"},{"issue":"1","key":"9255_CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369. doi: 10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"9255_CR15","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D et al (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192. doi: 10.1172\/JCI36470","journal-title":"J Clin Invest"},{"key":"9255_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. doi: 10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"issue":"2","key":"9255_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14737175.2014.877842","volume":"14","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) The pathomechanisms underlying Parkinson\u2019s disease. Expert Rev Neurother 14(2):199\u2013215. doi: 10.1586\/14737175.2014.877842","journal-title":"Expert Rev Neurother"},{"key":"9255_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152708784936680","volume":"7","author":"S Samantaray","year":"2008","unstructured":"Samantaray S, Ray SK, Banik NL (2008) Calpain as a potential therapeutic target in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 7:305\u2013312","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"20","key":"9255_CR19","doi-asserted-by":"crossref","first-page":"11486","DOI":"10.1073\/pnas.96.20.11486","volume":"96","author":"DC Shields","year":"1999","unstructured":"Shields DC, Schaecher KE, Saido TC, Banik NL (1999) A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. Proc Natl Acad Sci U S A 96(20):11486\u201311491","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9255_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jnc.12659","volume":"130","author":"N Trager","year":"2014","unstructured":"Trager N, Smith A, Wallace Iv G, Azuma M, Inoue J, Beeson C, Haque A, Banik NL (2014) Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. J Neurochem 130(2):268\u2013279. doi: 10.1111\/jnc.12659","journal-title":"J Neurochem"},{"key":"9255_CR21","doi-asserted-by":"crossref","unstructured":"Knaryan VH, Samantaray S, Park S, Azuma M, Inoue J, Banik NL SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone. J Neurochem 130 (2):280\u2013290. doi: 10.1111\/jnc.12629","DOI":"10.1111\/jnc.12629"},{"issue":"10","key":"9255_CR22","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1523\/JNEUROSCI.23-10-04081.2003","volume":"23","author":"SJ Crocker","year":"2003","unstructured":"Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS et al (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson\u2019s disease. J Neurosci 23(10):4081\u20134091","journal-title":"J Neurosci"},{"issue":"4","key":"9255_CR23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","volume":"73","author":"A Mouatt-Prigent","year":"1996","unstructured":"Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC (1996) Increased M-calpain expression in the mesencephalon of patients with Parkinson\u2019s disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73(4):979\u2013987","journal-title":"Neuroscience"},{"key":"9255_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuroscience.2011.06.007","volume":"192","author":"S Samantaray","year":"2011","unstructured":"Samantaray S, Knaryan VH, Le Gal C, Ray SK, Banik NL (2011) Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone. Neuroscience 192:263\u2013274. doi: 10.1016\/j.neuroscience.2011.06.007","journal-title":"Neuroscience"},{"key":"9255_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1369.034","volume":"1074","author":"S Samantaray","year":"2006","unstructured":"Samantaray S, Ray SK, Ali SF, Banik NL (2006) Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci 1074:349\u2013356. doi: 10.1196\/annals.1369.034","journal-title":"Ann N Y Acad Sci"},{"issue":"28","key":"9255_CR26","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","volume":"34","author":"D Games","year":"2014","unstructured":"Games D, Valera E, Spencer B, Rockenstein E, Mante M, Adame A, Patrick C, Ubhi K et al (2014) Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s disease-like models. J Neurosci 34(28):9441\u20139454. doi: 10.1523\/JNEUROSCI.5314-13.2014","journal-title":"J Neurosci"},{"issue":"5","key":"9255_CR27","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","volume":"170","author":"BM Dufty","year":"2007","unstructured":"Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM, Oxford JT, Feany MB et al (2007) Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol 170(5):1725\u20131738. doi: 10.2353\/ajpath.2007.061232","journal-title":"Am J Pathol"},{"issue":"21","key":"9255_CR28","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1021\/bi047846q","volume":"44","author":"AJ Mishizen-Eberz","year":"2005","unstructured":"Mishizen-Eberz AJ, Norris EH, Giasson BI, Hodara R, Ischiropoulos H, Lee VM, Trojanowski JQ, Lynch DR (2005) Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry 44(21):7818\u20137829. doi: 10.1021\/bi047846q","journal-title":"Biochemistry"},{"key":"9255_CR29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-4-2","volume":"4","author":"J Jin","year":"2007","unstructured":"Jin J, Shie FS, Liu J, Wang Y, Davis J, Schantz AM, Montine KS, Montine TJ et al (2007) Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. J Neuroinflammation 4:2. doi: 10.1186\/1742-2094-4-2","journal-title":"J Neuroinflammation"},{"issue":"25","key":"9255_CR30","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25(25):6016\u20136024. doi: 10.1523\/JNEUROSCI.0692-05.2005","journal-title":"J Neurosci"},{"issue":"5","key":"9255_CR31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","volume":"30","author":"D Sulzer","year":"2007","unstructured":"Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson\u2019s disease. Trends Neurosci 30(5):244\u2013250. doi: 10.1016\/j.tins.2007.03.009","journal-title":"Trends Neurosci"},{"issue":"5","key":"9255_CR32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1471-4159.2007.05091.x","volume":"104","author":"S Samantaray","year":"2008","unstructured":"Samantaray S, Knaryan VH, Butler JT, Ray SK, Banik NL (2008) Spinal cord degeneration in C57BL\/6N mice following induction of experimental parkinsonism with MPTP. J Neurochem 104(5):1309\u20131320. doi: 10.1111\/j.1471-4159.2007.05091.x","journal-title":"J Neurochem"},{"key":"9255_CR33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchemneu.2012.04.003","volume":"44","author":"G Vivacqua","year":"2012","unstructured":"Vivacqua G, Biagioni F, Yu S, Casini A, Bucci D, D\u2019Este L, Fornai F (2012) Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice. J Chem Neuroanat 44:76\u201385. doi: 10.1016\/j.jchemneu.2012.04.003","journal-title":"J Chem Neuroanat"},{"key":"9255_CR34","doi-asserted-by":"crossref","unstructured":"Litteljohn D, Mangano E, Clarke M, Bobyn J, Moloney K, Hayley S (2011) Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease. Parkinsons Dis 713517. doi: 10.4061\/2011\/713517","DOI":"10.4061\/2011\/713517"},{"issue":"5","key":"9255_CR35","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE (2010) Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol 184(5):2261\u20132271. doi: 10.4049\/jimmunol.0901852","journal-title":"J Immunol"},{"issue":"3","key":"9255_CR36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1568007033482887","volume":"2","author":"SK Ray","year":"2003","unstructured":"Ray SK, Banik NL (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2(3):173\u2013189","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"2","key":"9255_CR37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2004.01.065","volume":"1006","author":"B Chera","year":"2004","unstructured":"Chera B, Schaecher KE, Rocchini A, Imam SZ, Sribnick EA, Ray SK, Ali SF, Banik NL (2004) Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Res 1006(2):150\u2013156. doi: 10.1016\/j.brainres.2004.01.065","journal-title":"Brain Res"},{"issue":"5","key":"9255_CR38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Tredici Del","year":"2012","unstructured":"Del Tredici K, Braak H (2012) Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol 124(5):643\u2013664. doi: 10.1007\/s00401-012-1028-y","journal-title":"Acta Neuropathol"},{"issue":"7","key":"9255_CR39","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","volume":"182","author":"AD Reynolds","year":"2009","unstructured":"Reynolds AD, Stone DK, Mosley RL, Gendelman HE (2009) Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J Immunol 182(7):4137\u20134149. doi: 10.4049\/jimmunol.0803982","journal-title":"J Immunol"},{"key":"9255_CR40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1742-2094-8-166","volume":"8","author":"Y Couch","year":"2011","unstructured":"Couch Y, Alvarez-Erviti L, Sibson NR, Wood MJ, Anthony DC (2011) The acute inflammatory response to intranigral alpha-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J Neuroinflammation 8:166. doi: 10.1186\/1742-2094-8-166","journal-title":"J Neuroinflammation"},{"issue":"Pt 7","key":"9255_CR41","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awt134","volume":"136","author":"MJ Hurley","year":"2013","unstructured":"Hurley MJ, Brandon B, Gentleman SM, Dexter DT (2013) Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain J Neurol 136(Pt 7):2077\u20132097. doi: 10.1093\/brain\/awt134","journal-title":"Brain J Neurol"},{"issue":"4","key":"9255_CR42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/neur.1996.0042","volume":"5","author":"CL Liang","year":"1996","unstructured":"Liang CL, Sinton CM, Sonsalla PK, German DC (1996) Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5(4):313\u2013318","journal-title":"Neurodegeneration"},{"issue":"1","key":"9255_CR43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0169-328X(97)00305-7","volume":"54","author":"A McMahon","year":"1998","unstructured":"McMahon A, Wong BS, Iacopino AM, Ng MC, Chi S, German DC (1998) Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res Mol Brain Res 54(1):56\u201363","journal-title":"Brain Res Mol Brain Res"},{"issue":"1\u20132","key":"9255_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(94)90511-8","volume":"668","author":"A Mouatt-Prigent","year":"1994","unstructured":"Mouatt-Prigent A, Agid Y, Hirsch EC (1994) Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson\u2019s disease? Brain Res 668(1\u20132):62\u201370","journal-title":"Brain Res"},{"issue":"3","key":"9255_CR45","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jnr.21882","volume":"87","author":"JT Butler","year":"2009","unstructured":"Butler JT, Samantaray S, Beeson CC, Ray SK, Banik NL (2009) Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res 87(3):626\u2013635. doi: 10.1002\/jnr.21882","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"9255_CR46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jneuroim.2010.09.030","volume":"232","author":"AW Smith","year":"2011","unstructured":"Smith AW, Doonan BP, Tyor WR, Abou-Fayssal N, Haque A, Banik NL (2011) Regulation of Th1\/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol 232(1\u20132):179\u2013185. doi: 10.1016\/j.jneuroim.2010.09.030","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"9255_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(02)00142-X","volume":"129","author":"K Schaecher","year":"2002","unstructured":"Schaecher K, Rocchini A, Dinkins J, Matzelle DD, Banik NL (2002) Calpain expression and infiltration of activated T cells in experimental allergic encephalomyelitis over time: increased calpain activity begins with onset of disease. J Neuroimmunol 129(1\u20132):1\u20139","journal-title":"J Neuroimmunol"},{"issue":"6","key":"9255_CR48","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.131.6.2805","volume":"131","author":"WF Hickey","year":"1983","unstructured":"Hickey WF, Gonatas NK, Kimura H, Wilson DB (1983) Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 131(6):2805\u20132809","journal-title":"J Immunol"},{"key":"9255_CR49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367\u2013402. doi: 10.1146\/annurev-immunol-032713-120240","journal-title":"Annu Rev Immunol"},{"key":"9255_CR50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fncel.2014.00211","volume":"8","author":"R Cabezas","year":"2014","unstructured":"Cabezas R, Avila M, Gonzalez J, El-Bacha RS, Baez E, Garcia-Segura LM, Jurado Coronel JC, Capani F et al (2014) Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease. Front Cell Neurosci 8:211. doi: 10.3389\/fncel.2014.00211","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"9255_CR51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuint.2011.04.011","volume":"59","author":"ML McDowell","year":"2011","unstructured":"McDowell ML, Das A, Smith JA, Varma AK, Ray SK, Banik NL (2011) Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines. Neurochem Int 59(2):175\u2013184. doi: 10.1016\/j.neuint.2011.04.011","journal-title":"Neurochem Int"},{"issue":"3\u20134","key":"9255_CR52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000110642","volume":"14","author":"J Tichauer","year":"2007","unstructured":"Tichauer J, Saud K, von Bernhardi R (2007) Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 14(3\u20134):168\u2013174. doi: 10.1159\/000110642","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"9255_CR53","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.4049\/jimmunol.161.12.6896","volume":"161","author":"JM Weiss","year":"1998","unstructured":"Weiss JM, Downie SA, Lyman WD, Berman JW (1998) Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood\u2013brain barrier. J Immunol 161(12):6896\u20136903","journal-title":"J Immunol"},{"issue":"24","key":"9255_CR54","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1523\/JNEUROSCI.19-24-10923.1999","volume":"19","author":"N Laflamme","year":"1999","unstructured":"Laflamme N, Lacroix S, Rivest S (1999) An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood\u2013brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci Off J Socie Neurosci 19(24):10923\u201310930","journal-title":"J Neurosci Off J Socie Neurosci"},{"key":"9255_CR55","first-page":"275178","volume":"2014","author":"X Su","year":"2014","unstructured":"Su X, Federoff HJ (2014) Immune responses in Parkinson\u2019s disease: interplay between central and peripheral immune systems. BioMed Res Int 2014:275178. doi: 10.1155\/2014\/275178","journal-title":"BioMed Res Int"},{"issue":"3","key":"9255_CR56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai BS, Monahan AJ, Carvey PM, Hendey B (2007) Blood\u2013brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy. Cell Transplant 16(3):285\u2013299","journal-title":"Cell Transplant"},{"issue":"9","key":"9255_CR57","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","volume":"11","author":"DK Stone","year":"2009","unstructured":"Stone DK, Reynolds AD, Mosley RL, Gendelman HE (2009) Innate and adaptive immunity for the pathobiology of Parkinson\u2019s disease. Antioxid Redox Signal 11(9):2151\u20132166. doi: 10.1089\/ARS.2009.2460","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"9255_CR58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","volume":"57","author":"R Kortekaas","year":"2005","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57(2):176\u2013179. doi: 10.1002\/ana.20369","journal-title":"Ann Neurol"},{"issue":"10","key":"9255_CR59","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","volume":"190","author":"H Gonzalez","year":"2013","unstructured":"Gonzalez H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, Pacheco R (2013) Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson\u2019s disease. J Immunol 190(10):5048\u20135056. doi: 10.4049\/jimmunol.1203121","journal-title":"J Immunol"},{"issue":"1","key":"9255_CR60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(90)90184-O","volume":"98","author":"O Blin","year":"1990","unstructured":"Blin O, Ferrandez AM, Serratrice G (1990) Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci 98(1):91\u201397","journal-title":"J Neurol Sci"},{"issue":"3","key":"9255_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/mds.870130310","volume":"13","author":"JM Hausdorff","year":"1998","unstructured":"Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL (1998) Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson\u2019s disease and Huntington\u2019s disease. Mov Disord 13(3):428\u2013437. doi: 10.1002\/mds.870130310","journal-title":"Mov Disord"},{"issue":"6","key":"9255_CR62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0268-0033(01)00035-3","volume":"16","author":"ME Morris","year":"2001","unstructured":"Morris ME, Huxham F, McGinley J, Dodd K, Iansek R (2001) The biomechanics and motor control of gait in Parkinson disease. Clin Biomech (Bristol, Avon) 16(6):459\u2013470","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"7","key":"9255_CR63","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ptj\/76.7.763","volume":"76","author":"ME Morris","year":"1996","unstructured":"Morris ME, Matyas TA, Iansek R, Summers JJ (1996) Temporal stability of gait in Parkinson\u2019s disease. Phys Ther 76(7):763\u2013777, discussion 778\u2013780","journal-title":"Phys Ther"},{"issue":"Suppl 2","key":"9255_CR64","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1002\/mds.21984","volume":"23","author":"M Plotnik","year":"2008","unstructured":"Plotnik M, Hausdorff JM (2008) The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson\u2019s disease. Mov Disord 23(Suppl 2):S444\u2013450. doi: 10.1002\/mds.21984","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"9255_CR65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(03)00104-7","volume":"212","author":"JD Schaafsma","year":"2003","unstructured":"Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM (2003) Gait dynamics in Parkinson\u2019s disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 212(1\u20132):47\u201353","journal-title":"J Neurol Sci"},{"issue":"2","key":"9255_CR66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1109\/TNSRE.2009.2033062","volume":"18","author":"Y Wu","year":"2010","unstructured":"Wu Y, Krishnan S (2010) Statistical analysis of gait rhythm in patients with Parkinson\u2019s disease. IEEE Trans Neural Syst Rehabil Eng 18(2):150\u2013158. doi: 10.1109\/TNSRE.2009.2033062","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"issue":"8","key":"9255_CR67","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","volume":"120","author":"C Karachi","year":"2010","unstructured":"Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, Bardinet E, Prigent A et al (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120(8):2745\u20132754","journal-title":"J Clin Invest"},{"key":"9255_CR68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-0003-2-20","volume":"2","author":"I Amende","year":"2005","unstructured":"Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG (2005) Gait dynamics in mouse models of Parkinson\u2019s disease and Huntington\u2019s disease. J Neuroeng Rehabil 2:20. doi: 10.1186\/1743-0003-2-20","journal-title":"J Neuroeng Rehabil"},{"issue":"10","key":"9255_CR69","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/jnr.22699","volume":"89","author":"NR Goldberg","year":"2011","unstructured":"Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK (2011) Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. J Neurosci Res 89(10):1698\u20131706. doi: 10.1002\/jnr.22699","journal-title":"J Neurosci Res"},{"issue":"1","key":"9255_CR70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2(1):141\u2013151. doi: 10.1038\/nprot.2006.342","journal-title":"Nat Protoc"},{"issue":"5","key":"9255_CR71","first-page":"497","volume":"54","author":"MW Jakowec","year":"2004","unstructured":"Jakowec MW, Petzinger GM (2004) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson\u2019s disease, with emphasis on mice and nonhuman primates. Comp Med 54(5):497\u2013513","journal-title":"Comp Med"},{"issue":"5","key":"9255_CR72","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76(5):1265\u20131274","journal-title":"J Neurochem"},{"issue":"4","key":"9255_CR73","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","volume":"77","author":"NA Tatton","year":"1997","unstructured":"Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77(4):1037\u20131048","journal-title":"Neuroscience"},{"issue":"11","key":"9255_CR74","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/BF00964996","volume":"8","author":"NL Banik","year":"1983","unstructured":"Banik NL, Hogan EL, Jenkins MG, McDonald JK, McAlhaney WW, Sostek MB (1983) Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem Res 8(11):1389\u20131405","journal-title":"Neurochem Res"},{"issue":"2","key":"9255_CR75","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuroscience.2007.01.056","volume":"146","author":"S Samantaray","year":"2007","unstructured":"Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik NL (2007) The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146(2):741\u2013755. doi: 10.1016\/j.neuroscience.2007.01.056","journal-title":"Neuroscience"},{"issue":"3","key":"9255_CR76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/imm.12281","volume":"142","author":"JM God","year":"2014","unstructured":"God JM, Zhao D, Cameron CA, Amria S, Bethard JR, Haque A (2014) Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition. Immunology 142(3):492\u2013505. doi: 10.1111\/imm.12281","journal-title":"Immunology"},{"issue":"12","key":"9255_CR77","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/01.ALC.0000148103.09378.81","volume":"28","author":"A Kale","year":"2004","unstructured":"Kale A, Amende I, Meyer GP, Crabbe JC, Hampton TG (2004) Ethanol\u2019s effects on gait dynamics in mice investigated by ventral plane videography. Alcohol Clin Exp Res 28(12):1839\u20131848","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9255-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9255-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9255-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:53:31Z","timestamp":1748465611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9255-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9255"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9255-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,25]]}}}